Drug archive
Diphtheria, Tetanus, Pertussis, Hepatitis B, and Poliovirus Vaccine (Systemic)Proper Use
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Proper Use of This Vaccine
Dosing - The following information includes only the average doses of DTaP-HepB-IPV.
-
For injection
dosage form:
-
For prevention of diphtheria, tetanus, pertussis, hepatitis B, and
poliovirus:
- Adults and children greater than 7 years of age - Use is not approved.
- Children up to 6 weeks - Use is not approved.
- Children 6 weeks to 7 years of age - Three doses, 6 to 8 weeks apart. These doses are given into a muscle.
- Children already vaccinated with one or more doses of hepatitis B vaccine - Infants vaccinated with hepatitis B at or shortly after birth should be given 3 doses according to the recommended schedule. The doses are given into a muscle.
- Children previously vaccinated with Infanrix[reg ] - DTaP-HepB-IPV may be used to complete the first three doses of the DTaP and IPV series in infants who have received 1 or 2 doses of Infanrix[reg ] and are also due to get other components of DTaP-HepB-IPV.
- Geriatric - Use is not approved for this group.
-
For prevention of diphtheria, tetanus, pertussis, hepatitis B, and
poliovirus: